Code | 6861B | ||||||||||
MA number | 58/0489/15-S | ||||||||||
Product Form: | tbl plg 60x50 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 03.12.2015 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
PIL: | PIL_Bloxazoc 50 mg_tbl plg_11/2021.pdf |
SPC: | SPC_Bloxazoc 50 mg_tbl plg_11/2021.pdf |
Safety feature | Yes |
Data update: | 25.11.2021 |